Return to News List
Forum News
2026 6, 30

MGI出资5200万元,参与设立海洋生物制造专项基金

On 6 23, MGI Group issued an official announcement stating that the company intends to subscribe to 5200 yuan in capital using its own funds. Together with partners including Haida Win-Win (Shenzhen) Equity Investment Fund Management Co., Ltd., MGI will establish a specialized venture capital fund for marine biomanufacturing. This initiative aims to comprehensively expand into marine microbiology, synthetic biology, and deep-sea equipment sectors, leveraging capital to empower core technologies and drive the development of new quality productive forces in the ocean industry.

6 23,MGIIssue official announcement: The company intends to subscribe using its own funds.5200 ten thousand yuanin partnership with BGI Capital (Shenzhen) Equity Investment Management Co., Ltd. and other partners to jointly establishMarine Bio-Manufacturing Venture Capital FundComprehensively deploy across marine microbiology, synthetic biology, and deep-sea equipment sectors; leverage capital to empower hard-tech equipment and inject powerful momentum into the development of new productive forces in the ocean.

[Four Partners Join Forces: 1.26 Billion Special Fund Officially Launched]

The proposed fund shall be named Hainan Hengkeng Huada Win-Win Venture Capital Fund Partnership (Limited Partnership).Total fund size reaches 1.26 billion yuanUnites industry leaders, provincial state-owned enterprises, municipal investment holding platforms, and professional venture capital firms to achieve comprehensive synergy across industrial resources, local policies, and capital operations.

Regarding the capital structure, MGI and Hainan Nongken Investment Holding Group are tied as the largest limited partners, each contributing 5200 million yuan (accounting for 41.27% of the total). Sanya Fakong Industrial Investment Development Co., Ltd. contributed 2100 million yuan (16.67%). As the fund manager, Huada Win-Win contributed 100 million yuan as the general partner, assuming full responsibility for the fund's daily operations and investment management.

整只基金资金投向高度聚焦,将拿出1.2亿元专项投资国家生物制造业(海南)创新中心,持有该创新中心60%股权,依托海南自贸港得天独厚的海洋资源、区位优势与政策红利,Building China's leading full-chain service platform for marine biomanufacturing

[Focus on four core directions to solve pain points in the marine biotechnology industry]

For years, the marine biology sector has produced rich research outcomes but continues to face key industry pain points: the high difficulty of deep-sea resource extraction, challenges in scaling up synthetic biotechnology from lab to pilot scale, and a lack of incubation platforms for high-quality projects. As a result, many cutting-edge studies remain confined to the laboratory and fail to reach commercialization.

This national-level innovation center, established to bridge the final gap in translating research into industry, covers core business across the entire value chain: deepening marine microbial resource exploration and building specialized strain repositories; advancing foundational synthetic biology R&D and chassis cell engineering; optimizing bioprocessing workflows and establishing standardized pilot platforms; and prioritizing incubation of...Bio-based materials, marine innovative drugs, green bio-agrochemicals, and marine functional cosmeticsFour major industrialization project directions.

At the same time, the fund has established a robust investment decision-making mechanism by forming an Investment Decision Committee of 6 members. MGI can appoint 2 committee member(s) to participate in voting. Key matters such as major investments and project exits require approval from more than two-thirds of the committee members before execution. This ensures coordinated resource utilization while strictly maintaining risk control boundaries and safeguarding the legitimate rights and interests of the listed company.

Deep collaboration among government, enterprise, industry, and research institutions: leveraging complementary resources to drive industrial implementation.

本次基金组建,是一场精准匹配、优势互补的强强联手,每一方参与者都能发挥自身核心优势,构建闭环产业生态。

As the leading provider of life science equipment,MGIDeploy advanced hardware capabilities—including in-house sequencing platforms, automated laboratory equipment, and underwater in-situ bio-monitoring systems—to apply our mature life-manufacturing tools across new scenarios such as deep-sea biological exploration, strain screening, and automated fermentation, thereby expanding the boundaries of our core business applications.Hainan Hengken GroupLeveraging local state-owned enterprise strengths, we provide industrial parks, land assets, and agricultural and marine industry resources to resolve hardware and site challenges for project implementation.SanyaFa Kong Ze deeply aligns with Sanya Deep Sea Technology City's special policies and local industrial support resources to unlock regional implementation channels. Huada Gongying, leveraging years of biotech investment experience, manages the fund's investment pace while strengthening its return and risk control framework.

Through collaborative efforts, a complete industrial chain has been established—spanning deep-sea sample collection, genomic sequencing and analysis, strain engineering, pilot-scale testing, to industrial mass production. This fully resolves the industry-wide challenge of fragmented upstream and downstream operations in marine biotechnology.

Rising with the sea, empowering innovation through intelligence. From deep-sea gene exploration at depths of over 10,000 meters to the establishment of a national-level marine biomanufacturing platform, MGI has leveraged an investment of 5200 million as a fulcrum, uniting provincial and municipal state-owned assets in Hainan Province along with professional industrial capital to build a...Sequencing Hardware + Synthetic Biology + Industrial Investment + Free Trade Port Industrialization” 一体化生态。

In the future, the company will continue to unlock the value of marine life resources. Anchored in self-controlled intelligent manufacturing equipment for biomanufacturing, we will support China's development as a maritime power and a global leader in biomanufacturing, unlocking new growth opportunities in the blue economy.

2026 (2nd) EMBC Bio-Manufacturing Industry Conference & Exhibition (Summer)

2026 (2nd) EMBC Bio-Manufacturing Industry Conference & Exhibition (Summer)will be8 27-28Held in Shanghai, the exhibition will invite2000+ Attendees,100+Speaker,20+Premium exhibitors, featuring "Exhibitions - Conferences - Meetings - EventsFour core modules focused on "breakthroughs in fundamental research + cross-domain industrial implementation."

展览聚焦Medical Aesthetics, Bio-based Materials & Green Chemicals, Food, Agriculture, and AI EmpowermentExhibitor recruitment is now open. Contact us for details on participating in the exhibition.


Shanghai ICP Prep No. 2021023038-11|e1a3e515c7645245797692e708e85567